Branding/Logomark minus Citation Combined Shape Icon/Bookmark-empty Icon/Copy Icon/Collection Icon/Close Copy 7 no author result Created with Sketch. Icon/Back Created with Sketch. Match!
Doğuş Türkyılmaz
4Publications
Publications 4
Newest
Published on Jun 20, 2018in Turkish Journal of Hematology 0.78
Serife Solmaz Medeni1
Estimated H-index: 1
,
Doğuş Türkyılmaz + 8 AuthorsInci Alacacioglu8
Estimated H-index: 8
Source Cite
Published on Dec 1, 2014
Füsun Özdemirkıran3
Estimated H-index: 3
,
Kadriye Bahriye Payzin3
Estimated H-index: 3
+ 8 AuthorsHayri Özsan4
Estimated H-index: 4
Objective: Classically, chronic intravascular hemolysis, bone marrow failure, thrombosis in Paroxysmal Nocturnal Hemoglobinuria manifested (PNH) is a clonal disorder of hematopoietic stem cells. Eculizimab is a monoclonal antibody for the treatment of PNH, proven to reduce thrombotic episodes and the hemolysis. Us our PNH patients with a rare disease and we wanted to share our experience with eculizumab treatment. Methods: Dokuz Eylul University Faculty of Medicine, hematology USA and the Katip ...
Source Cite
Published on Dec 31, 1899
Şerife Solmaz Medeni , Ömür Gökmen Sevindik3
Estimated H-index: 3
+ 9 AuthorsGüner Hayri Özsan5
Estimated H-index: 5
Amac: Akut Myeloid Losemide (AML) konvansiyonel sitogenetik, FISH analizi ve molekuler genetik testler (Flt-3,NPM 1, inv 16 gibi) tedavi stratejisinde onem tasimaktadir. Calismamizda AML tanili hastalarimizin sitogenetik ve molekuler sonuclari ile tedavi yanitlarini degerlendirdik. Yontemler: Calismamiza Temmuz 2006-Haziran 2014 tarihleri arasinda Dokuz Eylul Universitesi Tip Fakultesi hematoloji kliniginde AML tanisi konan 140 hasta alinmistir. Bulgular: Ortanca izlem suresi 14,4 ay olan olgula...
1